Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

A non-exhaustive repository of COVID-19 related scientific publications undertaken by LSHTM researchers since the beginning of the outbreak.

WICID framework version 1.0: criteria and considerations to guide evidence-informed decision-making on non-pharmacological interventions targeting COVID-19.
Stratil, JM; VOSS, M; Arnold, L;
2020
BMJ global health, (2020).5 11 10.1136/bmjgh-2020-003699.
The seroprevalence of SARS-CoV-2 in patients on haemodialysis.
MAHALINGASIVAM, V; TOMLINSON, L;
2020
NATURE REVIEWS NEPHROLOGY, (2020).17 4 10.1038/s41581-020-00379-y.
Isolation thresholds for curbing SARS-CoV-2 resurgence.
YAKOB, L;
2020
BMJ Yale - medrixv preprint (2020). 10.1101/2020.11.20.20235291.
Modelling the test, trace and quarantine strategy to control the COVID-19 epidemic in the state of São Paulo, Brazil.
Amaku, M; Covas, DT; Bezerra Coutinho, FA; Azevedo Neto, RS; Struchiner, C; WILDER-SMITH, A; Massad, E;
2020
INFECTIOUS DISEASE MODELLING, (2020).6, 10.1016/j.idm.2020.11.004.
Remdesivir induced viral RNA and subgenomic RNA suppression, and evolution of viral variants in SARS-CoV-2 infected patients.
Boshier, FA T; Pang, J; Penner, J; Hughes, J; Parker, M; Shepherd, J; Alders, N; Bamford, A; Grandjean, L; Grunewald, S; Hatcher, J; Best, T; Dalton, C; Bynoe, PD; Frauenfelder, C; Köeglmeier, J; Myerson, P; Roy, S; Williams, R; THOMSON, EC; DE SILVA, TI; Goldstein, RA; Breuer, J;
2020
medRxiv preprint (2020). 10.1101/2020.11.18.20230599.
Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity.
Volz, E; Hill, V; McCrone, JT; Price, A; Jorgensen, D; O'Toole, Á; Southgate, J; Johnson, R; Jackson, B; Nascimento, FF; Rey, SM; Nicholls, SM; Colquhoun, RM; Da Silva Filipe, A; Shepherd, J; Pascall, DJ; Shah, R; Jesudason, N; Li, K; Jarrett, R; Pacchiarini, N; Bull, M; Geidelberg, L; Siveroni, I; COG-UK Consortium,; ... Connor, TR.
2020
Cell, (2020).184 1 10.1016/j.cell.2020.11.020.
Glasgow Early Treatment Arm Favirpiravir (GETAFIX) for adults with early stage COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Hanna, CR; Blyth, KG; Burley, G; Carmichael, S; Evans, C; Hinsley, S; Khadra, I; Khoo, S; Lewsley, L-A; Jones, RR; Sharma, R; Taladriz-Sender, A; THOMSON, EC; Scott, JT;
2020
TRIALS, (2020).21 1 10.1186/s13063-020-04891-1.
Integrating economic and health evidence to inform Covid-19 policy in low- and middle- income countries.
VASSALL, A; SWEENEY, S; Barasa, E; Prinja, S; KEOGH-BROWN, MR; Tarp Jensen, H; Smith, R; Baltussen, R; M Eggo, R; JIT, M;
2020
Wellcome Open Research, (2020).5, 10.12688/wellcomeopenres.16380.2.
Assessing COVID-19 through the lens of health systems' preparedness: time for a change.
El Bcheraoui, C; Weishaar, H; Pozo-Martin, F; HANEFELD, J;
2020
GLOBALIZATION AND HEALTH, (2020).16 1 10.1186/s12992-020-00645-5.
COVID-19 in humanitarian settings: documenting and sharing context-specific programmatic experiences.
SINGH, NS; Abrahim, O; Altare, C; Blanchet, K; FAVAS, C; Odlum, A; Spiegel, PB;
2020
Conflict and Health, (2020).14 1 10.1186/s13031-020-00321-w.